Tempus AI gets FDA clearance for ECG-based heart valve AI tool
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Oil hits five-month high as Houthi attacks stoke supply fears
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
| StemCells, Inc. (NASDAQ: TEM) | Delayed: 63.81 -3.95 (5.83%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $67.76 | 52 Week High | $0.45 | |||
| Open | $66.10 | 52 Week Low | $0.37 | |||
| Day High | $68.29 | P/E | N/A | |||
| Day Low | $61.51 | EPS | $-0.31 | |||
| Volume | 6,200,731 | |||||
